USD10
VKTX Shares
About Viking TherapeuticsViking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
USD10
VKTX Shares
About Viking TherapeuticsViking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Stats
TRADING WINDOW
Closed
OPENS AT
Mar 25 at 1:30 PM GMT+0
MARKET CAP
$3.76B
OPEN PRICE
Not enough data
LOW (1Y)
$18.92
HIGH (1Y)
$43.15
LOW (24H)
$31.71
HIGH (24H)
$32.78
VOLUME (24H)
$853.00
99.96%
Price history
Time | Price | Change |
|---|---|---|
Today | Not enough data | Not enough data |
1 Day | $32.67 | |
1 Week | $35.56 | |
1 Month | $33.12 | |
1 Year | $26.34 |